Home / M&A Activity / Triple-i Buys Cyber, Health-Focused IT Firm CCSi; Leo Phelan Comments

Triple-i Buys Cyber, Health-Focused IT Firm CCSi; Leo Phelan Comments

acquisitionInformation Innovators Inc. has acquired information technology contractor Creative Computing Solutions Inc. for an undisclosed sum in a push to grow in the cybersecurity and health services markets.

Triple-i said Tuesday CCSi is also an authorized third-party assessment organization for cloud service providers that seek to offer their products to federal agencies.

Rockville, Md.-based CCSi holds spots on governmentwide contract vehicles such as the Department of Homeland Security‘s potential seven-year, $22 billion EAGLE II program and the National Institutes of Health‘s CIO-SP3,  which is worth up to $20 billion over 10 years for all awardees.

The company is also a prime contractor on the Department of Veterans Affairs’ T4 vehicle and the Defense Department‘s TEAMS program.

Leo Phelan, general manager of Triple-i’s health solutions business, said the company made the transaction to build its presence in areas such as “clinical care design, informatics, research and analysis, education program design, health expert advisory services, program management, and infrastructure.”

“These are critical and compelling times for our government as they move toward a technological convergence, ” said Triple-i CEO Steve Ikirt.

SunTrust Robinson Humphrey acted as CCSi’s financial adviser for the transaction.

Check Also

F5 to Buy Shape Security for $1B; Francois Locoh-Donou Quoted

F5 Networks (Nasdaq: FFIV) has agreed to acquire Santa Clara, Calif.-based Shape Security for approximately $1B in cash as both companies aim to help government and enterprise customers secure digital experience with integrated offerings.

Paratek Secures $169M Anthrax Antibiotic Development Contract Under HHS Project BioShield

The Department of Health and Human Services has awarded Paratek Pharmaceuticals a potential a five-year, $169M contract to further develop an antibiotic drug as a potential treatment for inhalation anthrax.